GeneNews Ltd (TSE:GEN – Get Free Report) was up 7.1% on Tuesday . The stock traded as high as C$0.15 and last traded at C$0.15. Approximately 473,147 shares traded hands during mid-day trading, a decline of 68% from the average daily volume of 1,480,179 shares. The stock had previously closed at C$0.14.
GeneNews Price Performance
The firm has a fifty day moving average of C$0.15. The firm has a market cap of C$25.49 million and a PE ratio of -2.21.
About GeneNews
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Further Reading
- Five stocks we like better than GeneNews
- Why Invest in 5G? How to Invest in 5G Stocks
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- With Risk Tolerance, One Size Does Not Fit All
- Netflix Is On Track To Hit $1,000 By Christmas
- Insider Selling Explained: Can it Inform Your Investing Choices?
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.
